Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy? (Q34339983)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Beat Schwaller

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Walter Blum

series ordinal

1

1 reference

1 August 2017

Beat Schwaller

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

9 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

2077-2088

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

Malignant mesothelioma: facts, myths, and hypotheses

28 February 2020

cites work

1 reference

Malignant pleural mesothelioma: current treatments and emerging drugs.

21 January 2018

1 reference

Calretinin regulates Ca2+-dependent inactivation and facilitation of Ca(v)2.1 Ca2+ channels through a direct interaction with the α12.1 subunit

21 January 2018

1 reference

The continuing disappearance of "pure" Ca2+ buffers.

21 January 2018

1 reference

21 January 2018

Cytosolic Ca2+ buffers

1 reference

The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type

21 January 2018

1 reference

SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis

21 January 2018

1 reference

Mesothelioma epidemiology, carcinogenesis, and pathogenesis

21 January 2018

1 reference

Simian virus 40 transformation, malignant mesothelioma and brain tumors

21 January 2018

1 reference

Mesothelioma not associated with asbestos exposure

21 January 2018

1 reference

Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides

21 January 2018

1 reference

Association between the calcium-binding protein calretinin and cytoskeletal components in the human colon adenocarcinoma cell line WiDr

21 January 2018

1 reference

Mechanism of capsaicin receptor TRPV1-mediated toxicity in pain-sensing neurons focusing on the effects of Na(+)/Ca(2+) fluxes and the Ca(2+)-binding protein calretinin.

21 January 2018

1 reference

Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors

21 January 2018

1 reference

Calretinin and calretinin-22k increase resistance toward sodium butyrate-induced differentiation in CaCo-2 colon adenocarcinoma cells

21 January 2018

1 reference

Visualizing spatiotemporal dynamics of multicellular cell-cycle progression

21 January 2018

1 reference

Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma

21 January 2018

1 reference

Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune response-based therapies.

21 January 2018

1 reference

An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury.

21 January 2018

1 reference

Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma

21 January 2018

1 reference

Epithelial-mesenchymal transition in malignant mesothelioma

21 January 2018

1 reference

Calcium and cell death mechanisms: a perspective from the cell death community

21 January 2018

1 reference

Change of calretinin expression in the human colon adenocarcinoma cell line HT29 after differentiation.

21 January 2018

1 reference

Regulated redistribution of calretinins in WiDr cells.

21 January 2018

1 reference

Comparison of the Ca2+-binding properties of human recombinant calretinin-22k and calretinin.

21 January 2018

1 reference

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

21 January 2018

1 reference

Gene therapy for mesothelioma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23595591%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference